No services found
No Products found
Looking for dog, cat, or rabbit antibodies? Our ready-to-screen libraries are designed to deliver high-affinity, species-specific antibodies against virtually any antigen — in just one month. No animal immunization needed, no compromise on diversity or performance.
Have a different species in mind? Get in touch !
Whether you’re developing a therapeutic or diagnostic antibody, affinity to the target antigen is always a key success factor. At ProteoGenix, we routinely generate antibodies with nanomolar to picomolar affinities, tailored to each project. For therapeutic applications, higher affinity can lead to more effective treatments, allowing you to improve animal health with lower doses while reducing the risk of side effects. For diagnostics, it results in sharper signal-to-noise ratios and more reliable detection.
We’re committed to your project’s success. With our no win–no fee policy, you only pay if we succeed in generating antibodies against your target. No results? you won’t pay 100% of the service. It’s that simple.
By combining the power of artificial intelligence with cutting-edge wet lab technologies, we’ve expanded the possibilities of antibody discovery. For instance, if budget is your main constraint, we have developed an AI-driven specization tool that allows us to repurpose any existing antibody into one adapted to your target species. It’s a fast and highly cost-effective way to obtain a new antibody — at a price that’s hard to beat!
At ProteoGenix, we understand that speed is critical in your research timeline. That’s why we offer ultra-fast development solutions, with sequences delivered in as little as one month—or even faster.
With four proprietary antibody discovery platforms, we provide custom-tailored solutions for even the most specific or complex goals. Whether you need to:
We’ve got you covered—with flexible, high-performance solutions adapted to your project. Not seeing your exact need? No problem—we love a challenge. Looking for a trusted partner in veterinary antibody development? Let’s talk.
At ProteoGenix, you’re never “just another client.” When you choose to work with us, your success becomes our mission. That’s why we go beyond the basics and offer:
We anticipate and adapt to your needs—because that’s what a true partner does.
Clients who trust our expertise EL MAZOUARI K. Human-like target-binding proteins. WO2023161448A1. August 2023
This activity is experiencing steady growth, thanks to the diversity of technologies we offer. We currently manage approximately 50 animal antibody development projects each year, supporting a wide range of research needs across species and therapeutic areas.
At ProteoGenix, we’ve developed four state-of-the-art antibody discovery platforms—originally designed for therapeutic and diagnostic antibodies—now available to accelerate animal health research:
Thanks to our broad expertise, we’re now offering these technologies to veterinary researchers and biotech companies developing new therapeutics or diagnostic tools. And we’ve made it possible through two major innovations:
These advances are the result of years of R&D and a strong belief: veterinary research deserves the same advanced solutions as human health.
We primarily need the sequence of your antigen and its main characteristics.
The best method depends on several factors:
Our veterinary antibody experts are here to help you choose the best platform—you just need to ask!
+1 919 234 1277
inquiry-mabs@proteogenix.fr
Contact us
Got a question or need a quote? Message us and we’ll get back to you 48 hours or less.
Send
Your cart is currently empty.